Immunotherapy of autoimmune disorders using antibodies which target B-cells
US7074403B1 · kind B1 · utility
138Cited by
7References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 9, 2000 |
| Grant date | Jul 11, 2006 |
| Priority date | — |
| Expiry date | Jun 9, 2020 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/24
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Antibodies that bind with a B-cell antigen provide an effective means to treat autoimmune disorders. Antibodies and fragments, which may be conjugated or naked, are used alone or in multimodal therapies. The antibodies may be bispecific antibodies which may be produced recombinantly as fusion proteins, or as hybrid, polyspecific antibodies.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.